Central Ohio's biotech sector has exploded in just five years, with four companies now employing 1,200 people in high-paying jobs. After $600M acquisition, biotech founder finds her new venture ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug ...

Portage Biotech's PORT-7 showed >90% tumor growth inhibition with anti-PD1 combo in a murine mesothelioma model. PORT-7 single-agent activity outperformed anti-PD1 treatment alone; first-in-human ...

Ltd. iOx specializes in developing liposomal iNKT agonists, with its lead candidate, PORT-2, showing encouraging early clinical results. PRTG Price Action: Portage Biotech stock is up 102.93% at $ ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.

For Rituja Suraj Chavan, Managing Director of Valient Biotech Pvt Ltd, starting a company was never just about business—it was about making a difference. The company was founded with a dual ...

Biotech companies are innovators, which could translate into growth for your portfolio. It’s important to think long term and pay particular attention to a biotech’s pipeline -- today’s out ...

Pipeline and key clinical candidates for these companies: Arvinas is a clinical-stage biotechnology company that says it is “dedicated to improving the lives of patients suffering from ...

Spotlight Therapeutics, a Bay Area biotech startup that aimed to “democratize” CRISPR gene editing for patients, has shut down, per new reports. Endpoint reported that Spotlight began laying ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

U.S. and European biotech venture funding climbed to $28.1 billion in 2024 from $21.2 billion the prior year, according to HSBC Innovation Banking, which works with startups and venture investors.